AstraZeneca (AZN) said it is investing $50 billion in US manufacturing by 2030, following the lead of big pharma peers that ...

AstraZeneca unveils a $50 billion U.S. manufacturing expansion plan, anchored by a Virginia facility to boost drug output and ...

Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as ...

The dollar gave up an early advance and dropped to a 2.5-week low on today's weaker-than-expected US PMI and new home sales ...

One day after President Donald Trump accused former President Barack Obama of treason over the intelligence assessment that ...

Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

Union Minister for Commerce and Industry Piyush Goyal described the pact as 'game-changing' for Indian farmers, MSMEs, ...

Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: ...

The European Union is pushing for any future tariffs on pharmaceutical products sold to the United States to be capped at a ...

USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced that it will release financial results for the quarterly period ended June 30, 2025, after U.S. markets close on Monday, ...

The EU is also attempting to reduce its reliance on imports for critical raw materials, including rare earths. The EU's Critical Raw Materials (CRM) Act aims to extract 10% of the EU's annual CRM ...

President Donald Trump says the US has agreed to a ’’massive’’ trade deal with Japan, one of the country’s largest trading ...